These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26252256)

  • 1. Treatment options in the young patient with Graves' disease.
    Cheetham T; Bliss R
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):161-4. PubMed ID: 26252256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling.
    Kourime M; McGowan S; Al Towati M; Ahmed SF; Stewart G; Williamson S; Hunter I; Donaldson MDC
    Arch Dis Child; 2018 Jul; 103(7):637-642. PubMed ID: 29269558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive treatment of Graves' disease in children and adolescents.
    Król A; Czarniecka A; Jarząb B
    Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, management and outcomes of Graves' disease-real life data.
    Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP
    Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of antithyroid medication and radioiodine therapy in pediatric Graves' disease.
    Leu SW; Chi CS; Shu SG
    Acta Paediatr Taiwan; 2003; 44(4):220-6. PubMed ID: 14674226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease in children and adolescents: response to long-term treatment.
    Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
    Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment.
    Rivkees SA; Sklar C; Freemark M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3767-76. PubMed ID: 9814445
    [No Abstract]   [Full Text] [Related]  

  • 8. Pediatric Graves' disease: decisions regarding therapy.
    Okawa ER; Grant FD; Smith JR
    Curr Opin Pediatr; 2015 Aug; 27(4):442-7. PubMed ID: 26087421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adult Graves' disease.
    Corvilain B; Hamy A; Brunaud L; Borson-Chazot F; Orgiazzi J; Bensalem Hachmi L; Semrouni M; Rodien P; Lussey-Lepoutre C
    Ann Endocrinol (Paris); 2018 Dec; 79(6):618-635. PubMed ID: 30193753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
    Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
    Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
    [No Abstract]   [Full Text] [Related]  

  • 11. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological effects of Graves' disease therapy.
    Weetman AP
    Biomed Pharmacother; 1989; 43(8):587-92. PubMed ID: 2483678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should radioiodine be the first-line treatment for paediatric Graves' disease?
    West JD; Cheetham TD; Dane C; Natarajan A
    J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):797-804. PubMed ID: 25719296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The child with Graves disease.
    Gordner C
    J Pediatr Nurs; 2014; 29(3):288-90. PubMed ID: 24631225
    [No Abstract]   [Full Text] [Related]  

  • 15. Graves' disease: moving forwards.
    Lane LC; Wood CL; Cheetham T
    Arch Dis Child; 2023 Apr; 108(4):276-281. PubMed ID: 35831126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Graves Disease: A Review.
    Burch HB; Cooper DS
    JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Graves' disease: outcome and treatment.
    Gruñeiro-Papendieck L; Chiesa A; Finkielstain G; Heinrich JJ
    J Pediatr Endocrinol Metab; 2003 Dec; 16(9):1249-55. PubMed ID: 14714747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of radioiodine in adolescent Graves' disease.
    Teelucksingh S; Singh V; Balkaran B
    Ann Trop Paediatr; 2001 Dec; 21(4):335-8. PubMed ID: 11732151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
    Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
    Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.